全文获取类型
收费全文 | 5258篇 |
免费 | 426篇 |
国内免费 | 1篇 |
出版年
2023年 | 19篇 |
2022年 | 52篇 |
2021年 | 109篇 |
2020年 | 64篇 |
2019年 | 85篇 |
2018年 | 80篇 |
2017年 | 81篇 |
2016年 | 143篇 |
2015年 | 267篇 |
2014年 | 277篇 |
2013年 | 356篇 |
2012年 | 460篇 |
2011年 | 423篇 |
2010年 | 300篇 |
2009年 | 212篇 |
2008年 | 363篇 |
2007年 | 324篇 |
2006年 | 303篇 |
2005年 | 287篇 |
2004年 | 283篇 |
2003年 | 271篇 |
2002年 | 221篇 |
2001年 | 58篇 |
2000年 | 46篇 |
1999年 | 46篇 |
1998年 | 51篇 |
1997年 | 45篇 |
1996年 | 47篇 |
1995年 | 34篇 |
1994年 | 24篇 |
1993年 | 31篇 |
1992年 | 31篇 |
1991年 | 21篇 |
1990年 | 11篇 |
1989年 | 13篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 12篇 |
1982年 | 13篇 |
1981年 | 12篇 |
1979年 | 8篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1973年 | 8篇 |
1972年 | 8篇 |
1971年 | 7篇 |
1968年 | 7篇 |
1880年 | 8篇 |
排序方式: 共有5685条查询结果,搜索用时 31 毫秒
951.
Nuria Albet-Torres Marieke J. Bloemink Tom Barman Robin Candau Kerstin Fr?lander Michael A. Geeves Kerstin Golker Christian Herrmann Corinne Lionne Claudia Piperio Stephan Schmitz Claudia Veigel Alf M?nsson 《The Journal of biological chemistry》2009,284(34):22926-22937
Amrinone is a bipyridine compound with characteristic effects on the force-velocity relationship of fast skeletal muscle, including a reduction in the maximum shortening velocity and increased maximum isometric force. Here we performed experiments to elucidate the molecular mechanisms for these effects, with the additional aim to gain insight into the molecular mechanisms underlying the force-velocity relationship. In vitro motility assays established that amrinone reduces the sliding velocity of heavy meromyosin-propelled actin filaments by 30% at different ionic strengths of the assay solution. Stopped-flow studies of myofibrils, heavy meromyosin and myosin subfragment 1, showed that the effects on sliding speed were not because of a reduced rate of ATP-induced actomyosin dissociation because the rate of this process was increased by amrinone. Moreover, optical tweezers studies could not detect any amrinone-induced changes in the working stroke length. In contrast, the ADP affinity of acto-heavy meromyosin was increased about 2-fold by 1 mm amrinone. Similar effects were not observed for acto-subfragment 1. Together with the other findings, this suggests that the amrinone-induced reduction in sliding velocity is attributed to inhibition of a strain-dependent ADP release step. Modeling results show that such an effect may account for the amrinone-induced changes of the force-velocity relationship. The data emphasize the importance of the rate of a strain-dependent ADP release step in influencing the maximum sliding velocity in fast skeletal muscle. The data also lead us to discuss the possible importance of cooperative interactions between the two myosin heads in muscle contraction.Muscle contraction, as well as several other aspects of cell motility, results from cyclic interactions between myosin II motors and actin filaments. These force-generating interactions are driven by the hydrolysis of ATP at the myosin active site as outlined in Scheme 1 (1–3). In the absence of actin, the Pi and ADP release steps (k4 and k5) are rate-limiting for the entire cycle at high (>12 °C) and low temperatures, respectively (4–6). In the presence of actin, the rate of Pi release increases significantly, and the overall cycle is accelerated more than 2 orders of magnitude. The sliding velocity of myosin-propelled motors is generally believed to be rate-limited by actomyosin dissociation (rate constant k′5, k′6, or k′2 in Scheme 1) (7). Alternatively, some studies (8, 9) have suggested that the sliding velocity is determined by the fraction of myosin heads in the weak-binding states, AM4 ATP and AM ADP Pi. However, it is worth emphasizing that KT is very low under physiological conditions (1, 3) with low population of these states. For the same reason, the rate of dissociation of the AM complex is governed by K′1 and k′2.Open in a separate windowSCHEME 1.Simplified kinetics scheme for MgATP turnover by myosin (lower row) and actomyosin (upper row). Inorganic phosphate is denoted by Pi; MgATP is denoted by ATP, and MgADP is denoted by ADP; myosin is denoted by M. The states AM*ADP and AM ADP correspond to myosin heads with their nucleotide binding pocket in a partially closed and open conformation, respectively (7, 52). Rate constants are indicated by lowercase letters (rightward transitions, k2 − k5 and k′2 − k′5, or leftward transitions, k−2 − k−5 and k′−2 − k′−5) and equilibrium constants by uppercase letters (K1, K′1, KT, K3, K′3, K6, k′6, and KDP). The equilibrium constants are association constants except for simple bimolecular reactions where they are defined as ki/k−i.For the study of contractile mechanisms in both muscle and other types of cells, drugs may be useful as pharmacological tools affecting different transitions or states in the force-generating cycle. Whereas the use of drugs as tools may be less specific than site-directed mutagenesis, it also has advantages. The motor protein function may be studied in vivo, with maintained ordering of the protein components, e.g. as in the muscle sarcomere, allowing more insight into the relationship between specific molecular events and contractile properties of muscle. A drug that has been used quite extensively in this context is butanedione monoxime. The usefulness of this drug is based on firm characterization of its effect on actomyosin function on the molecular level (3, 10–13). More recently other drugs, like N-benzyl-p-toluene sulfonamide (14, 15) and blebbistatin (16), have been found to affect myosin function, and their effects at the molecular level have also been elucidated in some detail (14, 15, 17, 18). Both these drugs appear to affect the actomyosin interaction in a similar way as butanedione monoxime by inhibiting a step before (or very early in) the myosin power stroke, leading to the inhibition of actomyosin cross-bridge formation and force production.In contrast to the reduced isometric force, caused by the above mentioned drugs, the bipyridine compound amrinone (Fig. 1A) has been found to increase the isometric force production of fast intact skeletal muscles of the frog (19, 20) and mouse (21) and also of fast (but much less slow) skinned muscle fibers of the rat (22). In all the fast myosin preparations, the effect of about 1 mm amrinone on isometric force was associated with characteristic changes of the force-velocity relationship (Fig. 1B), including a reduced maximum velocity of shortening (19–22) and a reduced curvature of the force-velocity relationship (19–22). The latter effect was accompanied (20, 21) by a less pronounced deviation of the force-velocity relationship from the hyperbolic shape (23) at high loads. There have been different interpretations of the drug effects. It has been proposed (20–22) that amrinone might competitively inhibit the MgATP binding by myosin. However, more recently, results from in vitro motility assay experiments (24) challenged this idea. These results showed that amrinone reduces the sliding velocity (Vmax) at saturating MgATP concentrations but not at MgATP concentrations close to, or below, the Km value for the hyperbolic relationship between MgATP concentration and sliding velocity. Such a combination of effects is consistent with a reduced MgADP release rate (24) but not with competitive inhibition of substrate binding. However, effects of amrinone on the MgADP release rate have not been directly demonstrated. Additionally, in view of the uncertainty about what step actually determines the sliding velocity at saturating [MgATP] (see above and Refs. 7–9), it is of interest to consider other possible drug effects that could account for the data of Klinth et al. (24). These include the following: 1) an increased drag force, e.g. because of enhancement of weak actomyosin interactions; 2) a reduced step length; and 3) effects of the drug on the rate of MgATP-induced dissociation of actomyosin.Open in a separate windowFIGURE 1.A, structure of amrinone. B, experimental force-velocity data obtained in the presence (filled symbols) and absence (open symbols) of 1.1 mm amrinone. The data, from intact single frog muscle fibers, were obtained at 2 °C and fitted by Hill''s (42) hyperbola (lines) for data truncated at 80% of the maximum isometric force. Filled line, equation fitted to control data, a/P0* = 0.185; P0*/P0 = 1.196. Dashed line, amrinone, a/P0* = 0.347; P0*/P0 = 1.009. Force-velocity data were obtained in collaboration with Professor K. A. P. Edman. Same data as in Fig. 8 of Ref. 20. Note a decrease in maximum sliding velocity and curvature of the force-velocity relationship at low force, in response to amrinone. Also note that amrinone caused increased isometric force and a reduced deviation of the force-velocity relationship from the Hill''s hyperbola at high force. All changes of the force-velocity relationship were statistically significant (20), and similar changes were later also observed in intact mouse muscle and skinned rat muscle fibers. Data in Fig. 1 are published by agreement with Professor K. A. P. Edman.To differentiate between these hypotheses for the amrinone effects, and to gain more general insight into fundamental aspects of muscle function (e.g. mechanisms underlying the force-velocity relationship), we here study the molecular effects of amrinone on fast skeletal muscle myosin preparations in the presence and absence of actin.In vitro motility assay studies at different ionic strengths suggest that drag forces, caused by increased fraction of myosin heads in weak binding states, are not important for the effect of amrinone on sliding velocity. Likewise, optical tweezers studies showed no effect of the drug on the myosin step length. Finally, ideas that amrinone should reduce sliding velocity by reduced rate of MgATP-induced dissociation could be discarded because the drug actually increased the rate of this process. Instead, we found an amrinone-induced increase in the MgADP affinity of heavy meromyosin (HMM) in the presence of actin. Interestingly, similar effects of amrinone were not observed using myosin S1. As discussed below, this result and other results point to an amrinone-induced reduction in the rate of a strain-dependent MgADP release step. Simulations, using a model modified from that of Edman et al. (25), support this proposed mechanism of action. The results are discussed in relation to fundamental mechanisms underlying the force-velocity relationship of fast skeletal muscle, including which step determines shortening velocity and the possible importance of inter-head cooperativity. 相似文献
952.
953.
954.
955.
Steffen Kutter Manfred S. Weiss Georg Wille Ralph Golbik Michael Spinka Stephan K?nig 《The Journal of biological chemistry》2009,284(18):12136-12144
The mechanism by which the enzyme pyruvate decarboxylase from two yeast
species is activated allosterically has been elucidated. A total of seven
three-dimensional structures of the enzyme, of enzyme variants, or of enzyme
complexes from two yeast species, three of them reported here for the first
time, provide detailed atomic resolution snapshots along the activation
coordinate. The prime event is the covalent binding of the substrate pyruvate
to the side chain of cysteine 221, thus forming a thiohemiketal. This reaction
causes the shift of a neighboring amino acid, which eventually leads to the
rigidification of two otherwise flexible loops, one of which provides two
histidine residues necessary to complete the enzymatically competent active
site architecture. The structural data are complemented and supported by
kinetic investigations and binding studies, providing a consistent picture of
the structural changes occurring upon enzyme activation.Pyruvate decarboxylases (EC 4.1.1.1) catalyze the non-oxidative
decarboxylation of pyruvate, yielding acetaldehyde and carbon dioxide.
Together with the enzyme alcohol dehydrogenase (EC 1.1.1.1), which reduces the
acetaldehyde to ethanol with the help of the co-substrate NADH, it represents
the metabolic pathway of alcoholic fermentation.
PDC3 is localized in
the cytosol of cells from yeasts, plant seeds, and a few bacteria. The
catalytic activity of PDC depends on the presence of the cofactor thiamine
diphosphate (ThDP), which is bound mainly via a divalent metal ion (magnesium
in most cases) to the protein moiety. Many detailed kinetic studies have been
published on yeast PDC wild types
(1–9).
A number of ScPDC variants were analyzed, too
(1–9).
Some active site variants (E51A, D28A, E477Q) proved to be almost
catalytically inactive. PDCs are multisubunit enzymes. The typical molecular
mass of one subunit is 59–61 kDa. The tetramer is the catalytically
active state of most PDCs. Higher oligomers (octamers) have been described for
PDCs from plant seeds (10,
11) or some fungi
(12). However, studies on
structure function relationships of yeast PDCs showed that the dimer is the
minimum functional unit of the enzyme displaying considerable catalytic
activity (13,
14). The two closely related
pyruvate decarboxylases from Saccharomyces cerevisiae
(ScPDC) and Kluyveromyces lactis (KlPDC) are well
characterized ThDP-dependent enzymes, which share 86.3% identical amino acid
residues. They have been studied in great detail by means of kinetic
investigations and spectroscopic studies. Both enzymes are allosterically
regulated as reflected by sigmoid steady state kinetics and lag phases in
their progress curves. The substrate PYR activates the initially inactive
yeast PDCs in a time-dependent manner. Kinetic studies reveal a slow
isomerization as triggered by substrate binding to a separate regulatory site
(15). A number of substrate
surrogates have been identified, which are able to activate PDC as well. The
effects of pyruvamide (PA; for the chemical structure, see
Scheme 1) on the activation
kinetics have been studied in detail for ScPDC
(15) and for KlPDC
(16). Phosphonate analogues
(among them methyl acetylphosphonate, MAP,
Scheme 1) of pyruvate have been
applied to elucidate the catalytic cycle
(17–21)
or to trap reaction intermediates in crystal structures
(22–24).
Chemical modification of PDCs with group-specific reagents pointed to an
important role of cysteine residues
(25). Site-directed
mutagenesis of cysteine residues to alanine or serine demonstrated that
residue Cys-221 might be the decisive one for enzyme activation
(1,
4,
26,
27). Consequently, it was
postulated that the region around Cys-221 is the regulatory site of PDC, and
formation of a thiohemiketal at this side chain was proposed. However, a
number of questions remained elusive. (i) How is the activator fixed at the
regulatory site? (ii) What are the prime structural properties of the active
state as compared with the inactive state? (iii) How is the signal transmitted
from the regulatory to the active site? (iv) Which are the decisive features
of the active site in the activated state that render efficient catalysis
possible? To answer these questions, we present here the crystal structures of
KlPDC with the bound substrate surrogate MAP and of the
ScPDC variants D28E and E477Q with bound substrate PYR along with
kinetic studies on the activating effect of both activators and binding
studies using the small angle x-ray solution scattering (SAXS) method.Open in a separate windowSCHEME 1.Chemical structures of the substrate pyruvate, the activators pyruvamide
and methyl acetylphosphonate, and the thiohemiketal from pyruvate and
cysteine, respectively. 相似文献
956.
Jingxin Wang Naduparambil K Jacob Katherine J Ladner Amer Beg James D Perko Stephan M Tanner Sandya Liyanarachchi Richard Fishel Denis C Guttridge 《EMBO reports》2009,10(11):1272-1278
Nuclear factor (NF)-κB is a positive regulator of tumour development and progression, but how it functions in normal cells leading to oncogenesis is not clear. As cellular senescence has proven to be an intrinsic tumour suppressor mechanism that cells must overcome to establish deregulated growth, we used primary fibroblasts to follow NF-κB function in cells transitioning from senescence to subsequent immortalization. Our findings show that RelA/p65−/− murine fibroblasts immortalize at considerably faster rates than RelA/p65+/+ cells. The ability of RelA/p65−/− fibroblasts to escape senescence earlier is due to their genomic instability, characterized by high frequencies of DNA mutations, gene deletions and gross chromosomal translocations. This increase in genomic instability is closely related to a compromised DNA repair that occurs in both murine RelA/p65−/− fibroblasts and tissues. Significantly, these results can also be duplicated in human fibroblasts lacking NF-κB. Altogether, our findings present a fresh perspective on the role of NF-κB as a tumour suppressor, which acts in pre-neoplastic cells to maintain cellular senescence by promoting DNA repair and genomic stability. 相似文献
957.
958.
Lisa E. Creary Pinar Ulug Stephan Menzel Colin A. McKenzie Neil A. Hanchard Veronica Taylor Martin Farrall Terrence E. Forrester Swee Lay Thein 《PloS one》2009,4(1)
Fetal haemoglobin (HbF) is a major ameliorating factor in sickle cell disease. We investigated if a quantitative trait locus on chromosome 6q23 was significantly associated with HbF and F cell levels in individuals of African descent. Single nucleotide polymorphisms (SNPs) in a 24-kb intergenic region, 33-kb upstream of the HBS1L gene and 80-kb upstream of the MYB gene, were typed in 177 healthy Afro-Caribbean subjects (AC) of approximately 7% European admixture, 631 healthy Afro-Germans (AG, a group of African and German descendents located in rural Jamaica with about 20% European admixture), 87 West African and Afro-Caribbean individuals with sickle cell anaemia (HbSS), as well as 75 Northern Europeans, which served as a contrasting population. Association with a tag SNP for the locus was detected in all four groups (AC, P = 0.005, AG, P = 0.002, HbSS patients, P = 0.019, Europeans, P = 1.5×10−7). The association signal varied across the interval in the African-descended groups, while it is more uniform in Europeans. The 6q QTL for HbF traits is present in populations of African origin and is also acting in sickle cell anaemia patients. We have started to distinguish effects originating from European and African ancestral populations in our admixed study populations. 相似文献
959.
Bridge ES Schoech SJ Bowman R Wingfield JC 《Journal of experimental zoology. Part A, Ecological genetics and physiology》2009,311(1):35-44
Florida Scrub-Jays (Aphelocoma coerulescens) in a suburban environment with year-round access to multiple sources of abundant, human-source foods consistently breed earlier each year and have lower baseline levels of circulating corticosterone (CORT) than jays in a nearby wildland setting. These findings suggest that food supplies influence CORT levels, which in turn may partially determine the timing of reproduction. However, wildland birds with access to high-quality supplemental foods did not advance breeding or lower CORT levels to the degree observed in the suburbs. Therefore, rather than quality or quantity of food consumed, the perception of a reliable and predictable food supply may be an important factor in determining laying dates. If a predictable food supply accelerates the reproductive process, it follows that food provided on an unpredictable schedule may slow reproduction. We subjected captive Western Scrub-Jays (A. californica) to a 30-day photoperiod transition from short- to long-days and tested whether birds with access to food on an unpredictable schedule exhibited delayed or reduced production of reproductive hormones compared with birds given food on a predictable schedule. Baseline CORT concentrations increased slightly during the experiment, but did not differ between treatment groups. Birds with unpredictable food had slightly lower testosterone levels relative to controls, but there was no effect on estradiol or luteinizing hormone. Our findings offer weak support for the hypothesis that an unpredictable food supply will delay the onset of reproduction; however, the artificial lab environment may limit the application of these findings to free-living populations. 相似文献
960.
Ruth Halaban Michael Krauthammer Mattia Pelizzola Elaine Cheng Daniela Kovacs Mario Sznol Stephan Ariyan Deepak Narayan Antonella Bacchiocchi Annette Molinaro Yuval Kluger Min Deng Nam Tran Wengeng Zhang Mauro Picardo Jan J. Enghild 《PloS one》2009,4(2)
Decitabine, an epigenetic modifier that reactivates genes otherwise suppressed by DNA promoter methylation, is effective for some, but not all cancer patients, especially those with solid tumors. It is commonly recognized that to overcome resistance and improve outcome, treatment should be guided by tumor biology, which includes genotype, epigenotype, and gene expression profile. We therefore took an integrative approach to better understand melanoma cell response to clinically relevant dose of decitabine and identify complementary targets for combined therapy. We employed eight different melanoma cell strains, determined their growth, apoptotic and DNA damage responses to increasing doses of decitabine, and chose a low, clinically relevant drug dose to perform whole-genome differential gene expression, bioinformatic analysis, and protein validation studies. The data ruled out the DNA damage response, demonstrated the involvement of p21Cip1 in a p53-independent manner, identified the TGFβ pathway genes CLU and TGFBI as markers of sensitivity to decitabine and revealed an effect on histone modification as part of decitabine-induced gene expression. Mutation analysis and knockdown by siRNA implicated activated β-catenin/MITF, but not BRAF, NRAS or PTEN mutations as a source for resistance. The importance of protein stability predicted from the results was validated by the synergistic effect of Bortezomib, a proteasome inhibitor, in enhancing the growth arrest of decitabine in otherwise resistant melanoma cells. Our integrative analysis show that improved therapy can be achieved by comprehensive analysis of cancer cells, identified biomarkers for patient''s selection and monitoring response, as well as targets for improved combination therapy. 相似文献